抵抗VHL的机制损失引起的遗传和药理上的脆弱性
Jianfeng Ge1,2, Shoko Hirosue1, Leticia Castillon3
1MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK.
EMBO molecular medicine
|December 19, 2025
概括
希佩尔-林道 (VHL) 瘤抑制蛋白的损失会在癌细胞中产生脆弱性. 针对HIF1A通路可以消除VHL缺乏细胞,并影响对癌症疗法的耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 希佩尔-林道 (VHL) 瘤抑制剂对于细胞对缺氧的反应至关重要,并且是基于VHL的PROTACs的目标.
- VHL损失对于细胞增殖至关重要,但在细胞癌中起到瘤抑制作用.
研究的目的:
- 研究人类上皮细胞中VHL损失的功能后果.
- 确定消除VHL-null细胞的治疗策略.
主要方法:
- 全基因组CRISPR-Cas9查在人类上皮细胞中使用.
- 分析HIF1A/ARNT复合体在VHL缺乏细胞中的作用.
主要成果:
- VHL损失导致HIF1A/ARNT复合体介导的细胞健康和线粒体呼吸的抑制.
- VHL-null细胞表现出HIF1A依赖的脆弱性,可以被药理学药物向.
- 结合VHL/HIF1A无活化赋予了对基于VHL的原蛋白降解剂的耐药性,如ARV-771.
结论:
- VHL-HIF1A轴为准VHL缺陷的瘤克隆提供了治疗机会.
- 了解这一轴对于预测和克服对基于PROTAC的癌症疗法的耐药性至关重要.
更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.5K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.5K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Mismatch Repair
6.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.2K
Mismatch Repair
43.4K
Overview
43.4K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
In-vitro Mutagenesis
16.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.0K
Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
